Rare Disease Day 2023
- EasyM, blood test for residual myeloma activity, certified in US
- Fatty acid-binding proteins may be potential target for myeloma
- Prominent voices to help spotlight myeloma risk in Black communities
- Goal of Myeloma Action Month? Telling the community’s stories.
- Elranatamab under FDA priority review for hard-to-treat myeloma